Catalyst Brief

← Calendar

Readoutin 45d

Praxis Precision Medicines — 40 mg/day vormatrogine for 12 weeks

Phase 3 primary completion: Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures.

Date
Jan 2027
Type
Readout
Indication
Focal Epilepsy

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.